Are you searching for the best growth stocks for 2026 to supercharge your portfolio? The Tech + Healthcare Improvers portfolio is a dynamic investment strategy designed for investors seeking a sector ETF alternative with a focus on high-potential technology and healthcare stocks. With a balanced allocation of 54% in the technology sector and 38% in healthcare stocks, this portfolio of 13 holdings aims to capture growth opportunities while maintaining a diversification score of 70.4/100. Whether you're eyeing aggressive growth or exploring undervalued stocks, this portfolio offers a compelling mix for the Q1 2026 market outlook.
The stock selection is laser-focused on innovative companies like Automatic Data Processing Inc (ADP), indie Semiconductor Inc (INDI), and Ebang International Holdings (EBON) in tech, alongside healthcare pioneers such as Aptorum Group Ltd (APM), Align Technology Inc (ALGN), Alkermes Plc (ALKS), Amgen Inc (AMGN), and Arvinas Inc (ARVN). These picks are attractive for 2026 due to their strong innovation pipelines, current valuations, and potential to lead in their sectors—think cutting-edge biotech solutions and AI-driven tech advancements. Additional holdings like CCC Intelligent Solutions Holdings Inc (CCC) and Amesite Operating Co (AMST) round out the tech exposure, positioning this portfolio to benefit from emerging trends in the technology sector. However, investors should note market risks, including volatility in tech stocks and regulatory challenges in healthcare, which could impact returns. Sector-specific factors like FDA approvals or tech disruptions also play a role in the 2026 market outlook.
Crafted for aggressive growth investors and those building a retirement portfolio, this strategy suits anyone comfortable with medium-to-high volatility. If you're hunting for tech stocks to buy or undervalued healthcare stocks, the Tech + Healthcare Improvers portfolio could be your gateway to future gains.